Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Daré Bioscience (DARE) stocks in Canada
Learn how to easily invest in Daré Bioscience stocks.
Daré Bioscience is a biotechnology business based in the US. Daré Bioscience stocks (DARE.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.34 – an increase of 9.71% over the previous week. Daré Bioscience employs 20 staff and has a market cap (total outstanding stock value) of $88.9 million.
How to buy stocks in Daré Bioscience
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DARE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Daré Bioscience?
- Has coronavirus impacted Daré Bioscience shares?
- Daré Bioscience shares summary
- Compare share dealing platforms
- Is Daré Bioscience stock a buy or sell?
- Daré Bioscience performance over time
- Daré Bioscience's financials
- How volatile are Daré Bioscience shares?
- Does Daré Bioscience pay a dividend?
- Have Daré Bioscience shares ever split?
- Other common questions
Daré Bioscience stock price (NASDAQ:DARE)Use our graph to track the performance of DARE stocks over time.
Daré Bioscience shares at a glance
|Latest market close||$1.13|
|52-week range||$0.92 - $2.51|
|50-day moving average||$1.38|
|200-day moving average||$1.60|
|Wall St. target price||$7.20|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.63|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Daré Bioscience stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Daré Bioscience price performance over time
|1 week (2022-05-07)||N/A|
|1 month (2022-04-14)||N/A|
|3 months (2022-02-14)||N/A|
|6 months (2021-11-18)||-29.38%|
|1 year (2021-05-18)||-17.52%|
|2 years (2020-05-15)||10.78%|
|3 years (2019-05-17)||26.82%|
|5 years (2017-05-17)||180.40%|
Daré Bioscience financials
|Gross profit TTM||$-100,000|
|Return on assets TTM||-77.08%|
|Return on equity TTM||-205.82%|
|Market capitalisation||$88.9 million|
TTM: trailing 12 months
Daré Bioscience share dividends
We're not expecting Daré Bioscience to pay a dividend over the next 12 months.
Have Daré Bioscience's shares ever split?
Daré Bioscience's shares were split on a 1:10 basis on 19 July 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Daré Bioscience shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Daré Bioscience shares which in turn could have impacted Daré Bioscience's share price.
Daré Bioscience share price volatility
Over the last 12 months, Daré Bioscience's shares have ranged in value from as little as $0.92 up to $2.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Daré Bioscience's is 1.4233. This would suggest that Daré Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Daré Bioscience overview
Daré Bioscience, Inc. , a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar and vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ADARE-204 and ADARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women.
Stocks similar to Daré Bioscience
Daré Bioscience in the news
SEC filings reveal massive selling in media names, including Disney and Comcast
Daré Bioscience to Participate in H.C. Wainwright Global Investment Conference
DARE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Resultsof Operations (form 10-Q)
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.Read more…
Using our proprietary algorithm, we’ve found the best blue chip stocks on the TSX, NYSE and Nasdaq based on price, performance and more.Read more…
More guides on Finder
How to buy Hanover Bancorp, Inc. (HNVR) stock in Canada when it goes public
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
How to buy Actelis Networks (ASNS) stock in Canada when it goes public
Everything we know about the Actelis Networks IPO, plus information on how to buy in.
How to buy ProFrac Holding Corp (PFHC) stock in Canada when it goes public
Everything we know about the ProFrac Holding Corp IPO, plus information on how to buy in.
How to buy Wytec International (WYTC) stock in Canada when it goes public
Everything we know about the Wytec International IPO, plus information on how to buy in.
Here are some of the best stocks for inflation periods to reduce the negative impacts of inflation on your portfolio.
HSBC InvestDirect Review
Choose from many account and investment types to invest in global markets, but expect to pay high commissions with HSBC InvestDirect, which doesn’t have an app.
Our Flahmingo review tells you how to buy fractional shares of some of your favourite US companies with as little as $1.
How to buy Expeditors International of Washington stock in Canada
Steps to owning and managing EXPD stock, with 24-hour and historical pricing before you buy.
How to buy Perseus Mining stock in Canada
Steps to owning and managing PRU stock, with 24-hour and historical pricing before you buy.